bioAffinity Technologies (BIAF) EBIT Margin (2022 - 2026)
bioAffinity Technologies (BIAF) reported EBIT Margin of 267.62% for Q1 2026, down 12589.0% year-over-year from N/an in Q1 2025, and down 35.89% quarter-over-quarter from 196.94% in Q4 2025.
bioAffinity Technologies (BIAF) EBIT Margin (2022 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 5 years of EBIT Margin data on file, last reported at 267.62% in Q1 2026.
- EBIT Margin for Q1 2026 came in at 267.62%, down 12589.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 204.29% (down 9491.0% YoY), and the FY2025 annual result was 171.58%, down 7594.0% from the prior year.
- EBIT Margin eased to 267.62% in Q1 2026 per BIAF's latest filing, from 196.94% in the prior quarter.
- Over five years, EBIT Margin peaked at 80.84% in Q1 2024 and troughed at 169160.69% in Q1 2023.
- A 5-year average of 24179.53% and a median of 197.55% in 2025 frame the typical range for EBIT Margin.
- The sharpest annual moves came in 2024 and 2026: EBIT Margin soared 16907986 bps in 2024, then slumped 12589 bps in 2026.
- A 5-year view of EBIT Margin shows it stood at 69213.17% in 2022, then soared by 100 bps to 105.83% in 2023, then slipped by 26 bps to 133.47% in 2024, then plunged by 48 bps to 196.94% in 2025, then plunged by 36 bps to 267.62% in 2026.
- Business Quant data shows BIAF's EBIT Margin at 267.62% in Q1 2026, 196.94% in Q4 2025, and 158.56% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 21.74% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -13.42% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 12.38% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 25.23% |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | -267.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -267.62% |
| Dec 31, 2025 | -196.94% |
| Sep 30, 2025 | -158.56% |
| Jun 30, 2025 | -198.16% |
| Mar 31, 2025 | -141.73% |
| Dec 31, 2024 | -133.47% |
| Sep 30, 2024 | -83.98% |
| Jun 30, 2024 | -87.08% |
| Mar 31, 2024 | -80.84% |
| Dec 31, 2023 | -105.83% |
| Sep 30, 2023 | -768.72% |
| Jun 30, 2023 | -9,009.78% |
| Mar 31, 2023 | -169,160.69% |
| Dec 31, 2022 | -69,213.17% |
| Sep 30, 2022 | -84,883.13% |
| Jun 30, 2022 | -52,382.77% |